Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Han Bit Baek"'
Autor:
Kimberley D. Katleba, Maria-Malvina Tsamouri, Maitreyee Jathal, Han Bit Baek, Rebecca B. Armenta, Clifford G. Tepper, Gino Cortopassi, Paramita M. Ghosh, Maria Mudryj
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract The observed sex disparity in bladder cancer (BlCa) argues that androgen receptor (AR) signaling has a role in these malignancies. BlCas express full-length AR (FL-AR), constitutively active AR splice variants, including AR-v19, or both, and
Externí odkaz:
https://doaj.org/article/808e9dbfa3f84e6190abe7c760f86466
Autor:
Alexander J. Platero, Alan P. Lombard, Maria Mudryj, Paramita M. Ghosh, Ai Hong Ma, Stephen J. Libertini, Kristine S. Nishida, Chong-Xian Pan, Kimberley Katleba, Han Bit Baek, Maria Malvina Tsamouri
Publikováno v:
Cancer Lett
Bladder cancer (BlCa) exhibits a gender disparity where men are three times more likely to develop the malignancy than women suggesting a role for the androgen receptor (AR). Here we report that BlCa cells express low molecular weight (LMW) AR isofor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df581cc7afca6041c7c65a9f5c7d94fb
https://escholarship.org/uc/item/5rn509g0
https://escholarship.org/uc/item/5rn509g0
Autor:
Aleida Fernandez-Rubio, Regina F Gandour-Edwards, Robert H. Weiss, Han Bit Baek, Ruth Louise Vinall, Hiromi I. Wettersten, Kristine S. Nishida, Alan P. Lombard, Stephen J. Libertini, Paramita M. Ghosh, Yosef Landesman, Rachel M. Nakagawa, Kathleen D. Vidallo, Maria Mudryj, Salma Siddiqui
Publikováno v:
Oncotarget, vol 9, iss 77
Oncotarget
Oncotarget
Treatment options for high grade urothelial cancers are limited and have remained largely unchanged for several decades. Selinexor (KPT-330), a first in class small molecule that inhibits the nuclear export protein XPO1, has shown efficacy as a singl